Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

Balance Sheet: Liabilities and Stockholders’ Equity 

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Intuitive Surgical Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in thousands

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Accounts payable 255,100 193,400 188,700 147,000 121,200
Accrued compensation and employee benefits 648,400 535,600 436,400 401,600 350,100
Deferred revenue 506,700 468,800 446,100 397,300 377,200
Income and other taxes payable 125,400 154,400 111,400 96,100 54,100
Accrued construction-related capital expenditures 58,300 57,200 143,300 50,300 23,100
Other accrued liabilities 412,300 335,900 332,800 329,800 224,100
Other accrued liabilities 596,000 547,500 587,500 476,200 301,300
Current liabilities 2,006,200 1,745,300 1,658,700 1,422,100 1,149,800
Income taxes, long-term 193,600 239,000 233,800 288,000 316,600
Deferred revenue, long-term 91,400 54,100 45,600 41,000 36,800
Other long-term liabilities 225,800 175,200 106,100 110,300 100,300
Other long-term liabilities 510,800 468,300 385,500 439,300 453,700
Long-term liabilities 510,800 468,300 385,500 439,300 453,700
Total liabilities 2,517,000 2,213,600 2,044,200 1,861,400 1,603,500
Preferred stock, $0.001 par value, issuable in series; no shares issued and outstanding
Common stock, $0.001 par value 400 400 400 400 400
Additional paid-in capital 10,768,500 9,681,300 8,576,400 7,703,900 7,164,000
Retained earnings 7,011,800 6,803,300 4,743,000 3,500,100 4,760,900
Accumulated other comprehensive income (loss) 43,300 (51,300) (12,200) (162,500) (24,200)
Total Intuitive Surgical, Inc. stockholders’ equity 17,824,000 16,433,700 13,307,600 11,041,900 11,901,100
Noncontrolling interest in joint venture 117,700 95,900 89,700 70,700 50,400
Total stockholders’ equity 17,941,700 16,529,600 13,397,300 11,112,600 11,951,500
Total liabilities and stockholders’ equity 20,458,700 18,743,200 15,441,500 12,974,000 13,555,000

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


Total liabilities exhibited a consistent upward trend over the five-year period, increasing from US$1,603.5 million in 2021 to US$2,517.0 million in 2025. This growth was primarily driven by increases in both current and long-term liabilities. Simultaneously, total stockholders’ equity demonstrated volatility, decreasing initially before experiencing substantial growth, culminating in US$17,941.7 million in 2025. Consequently, the company’s capital structure shifted, with a decreasing proportion of assets financed by equity and an increasing proportion financed by debt.

Current Liabilities
Current liabilities increased steadily from US$1,149.8 million in 2021 to US$2,006.2 million in 2025. Significant contributors to this increase included accounts payable, accrued compensation and employee benefits, and deferred revenue. Accrued construction-related capital expenditures experienced a notable surge between 2021 and 2023, before decreasing in 2024 and stabilizing in 2025. The largest component of current liabilities consistently remained accrued compensation and employee benefits.
Long-Term Liabilities
Long-term liabilities showed a more moderate increase, moving from US$453.7 million in 2021 to US$510.8 million in 2025. Income taxes, long-term, and other long-term liabilities were the primary drivers of this growth. Deferred revenue, long-term, also contributed, with a more pronounced increase towards the end of the period.
Stockholders’ Equity Components
Common stock remained constant at US$0.4 million throughout the period. The most substantial component of stockholders’ equity was additional paid-in capital, which increased significantly from US$7,164.0 million in 2021 to US$10,768.5 million in 2025. Retained earnings experienced a decrease between 2021 and 2022, followed by a substantial recovery and growth, reaching US$7,011.8 million in 2025. Accumulated other comprehensive income (loss) fluctuated, moving from a loss of US$24.2 million in 2021 to a gain of US$43.3 million in 2025. Noncontrolling interest in joint venture also increased consistently over the period.
Total Liabilities and Stockholders’ Equity
The overall growth in total liabilities and stockholders’ equity reflects the company’s expansion. The total increased from US$13,555.0 million in 2021 to US$20,458.7 million in 2025. The increasing proportion of liabilities relative to equity suggests a potential shift towards greater financial leverage.

The observed trends indicate a growing company that is increasingly relying on debt financing. The significant increases in accrued compensation and employee benefits, alongside deferred revenue, suggest continued investment in personnel and future revenue recognition. The fluctuations in retained earnings warrant further investigation to understand the underlying factors driving these changes.